Ari Ne’eman
President and Co-founder
Autistic Self Advocacy Network
From this contributor
How governments should maintain disability services during the pandemic
People with disabilities are at increased risk of medical and other complications from coronavirus infection. There is a lot that governments can do to help them.
How governments should maintain disability services during the pandemic
Questions for Ari Ne’eman: Partnering with participants
Autistic adults should be partners in the research process, not just ‘subjects’ in a study, says Ari Ne’eman.
Questions for Ari Ne’eman: Partnering with participants
Will new DSM-5 autism criteria impact services?
The newest edition of the Diagnostic and Statistical Manual of Mental Disorders is an imperfect document, but it is far from the calamity that many have accused it of being, says Ari Ne’eman.
Explore more from The Transmitter
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.